Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Massimo Girardis and Giacomo Grasselli.
Massimo Girardis
Connection Strength
1.108
Giacomo Grasselli
  1. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med. 2021 Aug 08; 10(16).
    View in: PubMed
    Score: 0.240
  2. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest. 2021 08; 160(2):454-465.
    View in: PubMed
    Score: 0.235
  3. Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial). BMJ Open. 2021 02 11; 11(2):e036616.
    View in: PubMed
    Score: 0.232
  4. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020 12; 8(12):1201-1208.
    View in: PubMed
    Score: 0.225
  5. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med. 2021 09; 47(9):995-1008.
    View in: PubMed
    Score: 0.060
  6. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021 04 06; 25(1):128.
    View in: PubMed
    Score: 0.059
  7. Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy. Ann Intensive Care. 2020 Oct 12; 10(1):133.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.